BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2009
View Archived Issues
New PI3K inhibitors imparted in recent UCB patent
Read More
Roche researchers discover novel GABA-A alpha5 receptor ligands
Read More
Recent Roche patents divulge new trace amine receptor 1 ligands
Read More
Novel thrombin inhibitors discovered by AstraZeneca researchers
Read More
Novel 11beta-HSD1 inhibitors imparted by Taisho for type 2 diabetes
Read More
Schering-Plough reflects on Q4 developments
Read More
NanoBio develops novel nanoemulsion antimicrobial for cystic fibrosis-related pathogens
Read More
Roche divulges new chemokine CCR2 antagonists for cardiovascular disorders
Read More
MAGL inhibition may be useful in treating behavioral disorders
Read More
MediciNova reaffirms proposal to acquire Avigen
Read More
Genentech collaborates with National Cancer Institute on GDC-0449
Read More
EntreMed presents initial preclinical and phase I results for ENMD-2076
Read More
ViroPharma reports phase III maribavir trial results in bone marrow transplant
Read More
MCT1 inhibition blocks hypoxic-oxygenated tumor cell symbiosis and leads to cell death
Read More
Inhibitex completes phase I trials of FV-100 and selects HCV compounds for development
Read More
Coated magnetic beads capture infectious human influenza viruses
Read More
Lundbeck to acquire Ovation
Read More
NanoViricides presents update on development of nanoviricide against HSV and adenovirus
Read More
AstraZeneca licenses TRI compounds discovered by Mayo Clinic and Virginia Tech
Read More
Ligand earns milestone from Schering-Plough on progress of BACE drug for AD
Read More
Critical Outcome Technologies reports results from in vitro studies of oncology drug COTI-2
Read More
Roche commences tender offer to Genentech
Read More
Xoma and Takeda expand antibody technology collaboration
Read More
Priligy receives first regulatory approvals for premature ejaculation
Read More